Objections Filed on New Hampshire Meningitis Claims

By Walter F. Roche Jr.


A key official in the bankruptcy case of the New England Compounding Center has filed multiple objections to last minute claims filed in behalf of patients apparently treated at New Hampshire health facilities.
Paul Moore, the post confirmation officer in the NECC case, has charged that the filings are faulty and strain credibility.
Moore filed objections to requests for extensions for 18 patients to file claims despite the fact that the deadline passed some 18 months ago. All were filed by the same attorney.
According to Moore's filing the claims failed to include required information on the time and place the victims were alleged to have been injected with fungus tainted methylprednisolone acetate from NECC's Framingham, Mass. facilities.
"None of these motions is supported by a declaration or affidavit," Moore's motion states.
The objections are the latest development in the bankruptcy of the firm blamed for a 2012 fatal outbreak of fungal meningitis. The outbreak sickened 778 patients, killing 76 of them.
More than $200 million is expected to be available for victims of the outbreak, their survivors and a handful of other creditors.
Moore charged that some of the extension requests were "nonsensical" because claims on behalf of those victims already had been filed.
He also noted that the numbers of victims claimed to have suffered joint infections from the NECC drugs exceeded by nine times the total  number of victims in New Hampshire in that category as compiled by the U.S. Centers for Disease Control and Prevention. The CDC count listed a total of 14 New Hampshire victims.
Contact: wfrochejr999@gmail.com